A deep knowledge of the role of both the TENM4 protein and miR-708 in breast cancer cells and tumors will facilitate the investigation of combinatorial strategies that aim to halt tumor progression and prolong cancer patient survival. This evidence concerns the gene TENM4 and neoplasm.